Next Article in Journal
A Four-Week High-Fat Diet Induces Anxiolytic-like Behaviors through Mature BDNF in the mPFC of Mice
Previous Article in Journal
Pragmatic Communication Deficit and Functional Outcome in Patients with Right- and Left-Brain Damage: A Pilot Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Implementing an Early Detection Program for Autism Spectrum Disorders in the Polish Primary Healthcare Setting—Possible Obstacles and Experiences from Online ASD Screening

by
Mateusz Sobieski
*,
Urszula Grata-Borkowska
and
Maria Magdalena Bujnowska-Fedak
Department of Family Medicine, Wroclaw Medical University, Syrokomli 1, 51-141 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Brain Sci. 2024, 14(4), 388; https://doi.org/10.3390/brainsci14040388
Submission received: 23 March 2024 / Revised: 8 April 2024 / Accepted: 15 April 2024 / Published: 16 April 2024
(This article belongs to the Section Psychiatric Diseases)

Abstract

:
A screening questionnaire for autism symptoms is not yet available in Poland, and there are no recommendations regarding screening for developmental disorders in Polish primary healthcare. The aim of this study was to assess the opinions of parents and physicians on the legitimacy and necessity of screening for autism spectrum disorders, potential barriers to the implementation of the screening program, and the evaluation and presentation of the process of online ASD screening, which was part of the validation program for the Polish version of one of the screening tools. This study involved 418 parents whose children were screened online and 95 primary care physicians who expressed their opinions in prepared surveys. The results indicate that both parents and doctors perceive the need to screen children for ASD in the general population without a clear preference as to the screening method (online or in person). Moreover, online screening is considered by respondents as a satisfactory diagnostic method. Therefore, online screening may prove to be at least a partial method of solving numerous obstacles indicated by participants’ systemic difficulties including time constraints, the lack of experienced specialists in the field of developmental disorders and organizational difficulties of healthcare systems.

1. Introduction

Autism spectrum disorders (ASD) are neurodevelopmental conditions of undetermined etiology, most often manifested in early childhood, which affect daily activity and are characterized primarily by difficulties in the sphere of communication and interpersonal interactions as well as restricted interests or repetitive behaviors, with prevalence estimated to 1/100 worldwide [1,2]. There are no reliable data available on the prevalence of ASD in Poland—according to official data from the Polish National Health Fund from 2012, the prevalence rate of ASD in individuals under the age of 18 in Poland is 3.4 cases per 10,000 children [3]. More recent preliminary data from two Polish provinces estimate that ASD occurs in one in 286 children [4]. It is not entirely clear why the reported prevalence of ASD in Poland is lower than in neighboring countries (e.g., in Germany—0.38%) and lower than assumed, based on newer data from European Union countries [5,6]—it may be the result of lacking readily available tools for the screening and diagnosis of ASD, insufficient awareness of this problem of healthcare professionals (HCPs) and systemic difficulties and constraints.
Accelerated diagnosis of ASD enables initiation of an early, appropriately adjusted therapy [7]. First symptoms of ASD usually appear during infancy or early childhood—prodromal symptoms may be visible even as early as 6 months of a child’s life [7,8] and usually reliable diagnosis of ASD in a child can be made as early as 2–3 years of age [9]. The younger the child, the better the results of therapy that can be achieved in the area of communication and social interaction, cognitive abilities, speech development or behavior appropriate to the situation, which improves the quality of life of people with ASD, reduces the risk of mental disorders, and significantly reduces the ASD burden [10,11,12,13]. The burdens associated with the diagnosis of ASD in a child in the family include lowering the quality of life of the parents of a child with ASD, lowering the quality of interaction with the child and increasing perceived parental stress [14,15].
For this reason, the American Academy of Pediatrics recommends screening at 18 and 24 months of age as part of primary care during well-child care visits [16]. It appears that the increasing availability of screening significantly lowered the age of ASD diagnosis in the US, with diagnosis before the age of 4 made in 71% of children (2018) compared to 58% in 2014 [17,18]. However, a US Preventive Services Task Force from 2016 report shows insufficient evidence to recommend universal ASD screening [19]. On the other hand, there is evidence suggesting that including screening tools in routine medical appointments may result in earlier and more accurate identification of children who need further help than relying solely on clinical impressions, which is particularly important when care providers are less experienced in diagnosing ASD [20]. Moreover, the use of public ASD screening may reduce social inequalities in terms of the age of diagnosis and access to further therapeutic activities [21,22]. The conclusions of both reports indicate the need for further research on screening tools and their effectiveness, as well as on the effectiveness of further proceedings after screening [23].
Throughout infancy and early childhood, primary care professionals are the professionals with whom a young child most often comes into contact [24]. During this time, numerous meetings with doctors, nurses, midwives and other HCPs take place—as a result of visits due to the child’s illness, well-child check-ups or qualifying for vaccinations [25]. This enables close observation of development of the child and detection of developmental disorders [26]. Primary care professionals are believed to have the greatest influence on the early diagnosis of ASD (especially due to performing screening for developmental disorders (DD)), and they are responsible for the significant trend in the decline in the average age of children when diagnosed with autism spectrum disorders [26]. In addition, family doctors are coordinators of diagnostics and treatment performed by many of the further specialists, as well as “caregivers” of their patients not only on the health issues, but also on the social issues—which is necessary in the event of ASD in a child.
In Poland, well-child care visits have been conducted in primary healthcare clinics since the 1950s. The system of preventive healthcare for children is based on the principle of continuity of care—according to this assumption, the same doctor looks after a child in health and in sickness. After the newborn is discharged from the hospital, parents are obliged to report the child to a selected primary care clinic. Well-child care visits take place at the ages of 2, 6, 9, and 12 months and later at 2, 4 and 5 years of age. During the latter, an indicative examination of hearing (assessment of hearing behavior and the “show what you hear” test) and vision (especially in the direction of strabismus, later—also other disorders) is performed [27]. At 5–6 years of age, an indicative study of motor and psychosocial development should be carried out on the basis of interviews and observation, but it is rarely a validated, structured study [28]. Until then, the assessment of psychomotor development is primarily an assessment of the child’s time to reach milestones—there are no other established guidelines for the use of any tools for DD screening in children. In the case of suspicion of DDs, the child is referred to appropriate psychological and pedagogical clinics, where further examinations and consultations are carried out [29]. The validated diagnostic methods available in Poland include Level 2 tools, Autism Spectrum Rating Scales (ASRS) and Social Communication Questionnaire (SCQ), and Level 3 tools, Autism Diagnostic Observation Schedule (ADOS-2) and Psychoeducational Profile, Third Edition—PEP-3-PL [30,31,32,33]. Research on the Polish version of Autism Diagnostic Interview-Revised (ADI-R) is in progress [34]. During the final diagnosis, children with visible developmental disorders may be covered by the Early Development Support program—comprehensive, multidisciplinary activities to support the child’s psychomotor development through the intervention of therapists (psychologists, speech therapists, educators, SI therapists); however, they must be referred there by a doctor or preschool teacher.
In order to increase the effectiveness of early detection of autism spectrum symptoms, many tools have been created to facilitate this process for healthcare workers. Due to the lack of standardized tools for ASD screening in Poland, we started the “Spojrzeć w oczy” (eng. “Look in the eyes”) project. The aim of this project was to validate the Polish version of the Communication and Symbolic Behavior Scale-Developmental Profile Infant-Toddler Checklist (CSBS-DP ITC). The CSBS-DP ITC is one of the available tools for the early detection of symptoms of autism spectrum disorders consisting of 24 items, filled out by parents and guardians [35]. The CSBS-DP ITC can be used in ASD screening for the general population of children aged 6 to 24 months in a primary care setting. In previous studies, we showed that the Polish version of the CSBS-DP ITC has good psychometric properties and relatively high specificity and sensitivity and can be used as an effective screening tool [36,37].
During the planning of this study, the COVID-19 pandemic spread globally, which prevented efficiently carrying out the stationary study in primary healthcare clinics. The pandemic has made it necessary to introduce solutions that would allow access to remote medical services, which reduced the risk of coronavirus infection [38,39]. For this reason, it was necessary to create an electronic version of the CSBS-DP ITC questionnaire to be completed by parents at home. Then, the results of examination, instead of being assessed by individual healthcare professionals (HCPs, e.g., GPs, pediatricians, nurses, psychologists), were assessed directly by specialists involved in the project. Epidemiological situation forced the screening to be carried out in a unique way, using the online version, without direct contact with the examined person. The use of telemedicine made it possible to contact the patient, perform the screening, conduct follow-up tests and possibly dispel the parents’ doubts and questions.
The aim of this paper is to assess opinions of HCPs and parents performing electronic screening and to present the experiences from one of the first attempts to conduct such a screening program. In addition, we wanted to assess the possible constraints in usage of ASD screening tools in HCPs’ everyday practice. Approval from the Bioethics Committee of the Wroclaw Medical University was obtained to conduct this study (number KB—641/2020). All procedures were performed in accordance with the 1964 Helsinki declaration and its later amendments.

2. Materials and Methods

2.1. Assessment of ASD Electronic Screening by Parents

We sent e-mail invitations to 1461 parents of children whose applications in the first phase of the “Spojrzec w oczy” project were included in the assessment of the psychometric values of the CSBS-DP ITC (the criteria for inclusion of children in this study regarding the properties of the questionnaire were being a resident of Poland, the age 6–24 months and usage of Polish as the main language by both parents) [36]. We asked parents to fill out an electronic short questionnaire about their feelings on electronic screening for developmental disorders, recording their age, level of education, place of residence and subjective information technology (IT) proficiency on a scale from 1 to 10 (where 1—is the lowest, 10—the highest) as factors potentially influencing the assessment of the diagnostic process [40,41]. A translated version of the survey is available as Supplementary File S1. We did not link parents’ answers to their child’s results in the CSBS-DP ITC questionnaire to maintain anonymity; however, we asked them to select if they benefited from additional contact with people involved in the project (e.g., further diagnostics, specialist advice) or if their child was diagnosed with ASD or other developmental disorders, as a factor that could potentially increase satisfaction with online screening. The survey was made available on the project’s website—it is available only through the appropriate link, sent only to the parents included in this study. Invitations to evaluate the project were sent on 9 January 2023 and responses were collected until 18 January 2023.

2.2. Assessment of ASD Electronic Screening by Doctors and Potential Difficulties in Implementing the ASD Screening Program

In order to recruit physicians for this study, we sent e-mail invitations to members in the Polish Society of Family Medicine and we propagated the survey on the project’s social media profiles. The doctors were verified with their profession practice number—a document possessed by every doctor practicing in Poland. The survey consisted of 18 questions, 7 of which concerned statistical data—age, sex, main place of work, work experience, and the percentage of children with developmental disorders (DD) under their own medical care. The remaining ones touched upon aspects of the use of diagnostic methods in clinical practice, further proceedings when DD is suspected, the willingness to use screening methods during medical visits, the assessment of potential difficulties and limitations in introducing screening tests, and the positives and negatives resulting from online DD screening. A translated version of the survey for doctors is available as Supplementary File S2. Applications were collected from 31 July 2023 to 1 February 2024.

2.3. Statistical Analysis

All the analyses presented in this manuscript were performed using Statistica 13.3 software. The Shapiro–Wilk normality test was applied to check the normal distribution using 0.05 as a significance level. None of the examined variables met the criterion of normality of distribution; therefore, non-parametric tests were used for further analysis. The dependence of the variables on the categories of qualitative variables was tested using the non-parametric Kruskal–Wallis test. This test enabled a direct comparison of the value of a quantitative variable between the two categories of a qualitative variable. In the case of qualitative variables, the uniformity of the category distribution was tested with the chi-square uniformity test (one sample proportions test). In some cases, Spearman’s rank correlation was used, allowing variables on ordinal and quantitative scales that did not have a normal distribution to be correlated with each other. In the case of a small number of respondents in subgroups, the Yates correction was used in the chi-square test. A significance level of 0.05 was set for all tests. In the case of some of the examined features, only a descriptive interpretation was possible. This is mainly due to the inability to conduct further statistical analyses—these variables cannot be tested for homogeneity. The respondents could indicate several categories at the same time, so the categories do not meet the separability condition required for homogeneity testing.

3. Results

We received a positive response and a fully completed survey from 418 parents taking part in the “Spojrzeć w oczy” project, giving a response rate of 28.6%. Due to forcing the answers to individual questions and the full anonymity of the survey, it was not necessary to exclude any submissions. The number of participants exceeds the minimum sample size to achieve a confidence level of 95% and a margin of error of 5% in the Polish population (the calculated minimum sample size was 384) [42]. All submissions were completed by female participants except one. The mean age of the parents was 33.86 years (SD = 4.12) and the mean subjective IT proficiency was 8.52 (SD = 1.25). Parents’ full sociodemographic characteristics are presented in Table 1.
Among the parents who took part in the ASD electronic screening assessment, 38 additionally contacted us for more information and diagnostic and therapeutic assistance via e-mail and telephone. A total of 30 of their children were diagnosed with a developmental disorder—21 with ASD, 8 with speech development delay, and 1 with sensory integration disorder.
Of all the parents, only 4 (0.95%) had not heard of ASD before and 184 (44.02%) did not suspect any developmental disorders in their child—in this group, one child was diagnosed with ASD, the other 3—with language delay (LD). Each parent was asked to answer questions about ASD awareness and opinions on ASD screening—both online and in person. Chi-square tests and the Kruskal–Wallis test were used for this analysis, depending on the nature of the studied variables. The collected results are presented in Table 2 and Table 3.
The significant majority of parents (99.04% of all, N = 414) participating in this study were aware of the issue of ASD at least to a basic extent before the screening test. Nevertheless, there is a significant difference in the level of awareness of ASD among parents with lower education, living in rural areas and with lower IT proficiency compared to other parents (χ2 = 13.013, p = 0.005; χ2 = 13.398, p = <0.001; H = 14.801, p = 0.011, respectively). Moreover, as many as 98.09% of parents (N = 410) believe that ASD screening should be mandatory, 98.56% (N = 412) would participate in screening for developmental disorders in their next child again, and 97.13% (N = 406) would participate in online screening. The percentage of parents willing to participate again for another child is lower for parents living in smaller towns. The parents’ opinion differs widely in the case of preferences for the form of screening (online or stationary)—a slight majority prefer the online version (52.15%, N = 218), but this does not depend on place of residence, education or the fact of receiving a diagnosis of developmental disorders in a child—the only factor influencing the preference for the online method is higher IT proficiency (H = 16.212; p = 0.006).
A rather intriguing issue is the fact that parents whose children were finally diagnosed with developmental disorders report much more often than others that they have had the thought that their child may be at risk of suffering from ASD (χ2 = 12.350, p = <0.001).
We also asked parents four questions regarding their assessment of the electronic screening carried out by us as part of the “Spojrzeć w oczy” project using the Polish online-version of the CSBS-DP ITC questionnaire. Responses to questions were based on a five-point Likert scale. The Kruskal–Wallis test and Spearman’s rank correlation were used for this analysis. The results regarding the assessment of the quality of online screening and satisfaction with participation in this study depending on age, IT proficiency, place of residence and education are included in Table 4 and Table 5.
Collected data indicate a very high overall assessment of the online screening conducted as part of the project by parents. Opinions are characterized by high homogeneity in terms of the examined features, with a few exceptions. Parents living in small towns rated the possibility of contact and the possibility of receiving help the lowest (H = 10.794, p = 0.013 and H = 21.323, p = <0.001, respectively); similarly, people with higher education rated the possibility of obtaining appropriate help lower than parents with secondary education (H = 6.043, p = 0.048). Moreover, there is a very weak negative correlation indicating that older parents evaluate the possibility of obtaining further information and answers from examiners during online screening lower than younger parents (R = −0.104, p = 0.033).
In order to obtain doctors’ opinions on electronic ASD screening and potential limitations in the implementation of ASD screening in everyday practice, doctors from the Polish Society of Family Medicine were invited to participate in the second part of this study. Finally, 95 doctors took part in this study. The exact number of Society members is not officially available; according to Facebook data, the post reached approximately 1320 users. Mean age of the doctors was 32.58 years (SD = 5.24) and mean subjective IT proficiency was 8.33 (SD = 1.32). The average length of service in primary healthcare facilities of the respondents was 5.23 years (SD = 4.68). Full doctors’ sociodemographic characteristics are presented in Table 6.
Physicians were asked about their own methods of management of a pediatric patient in case of suspected developmental disorders—whether they rely on their own clinical assessment or the results of additional tests when choosing further treatment, and whether they use screening methods in their everyday work. In addition, we asked for information on whether they use given methods in all children or only those from the risk group, and what actions are taken when observing DD in a patient; finally, we asked doctors to choose their preferred ASD screening option. Chi-square tests and the Kruskal–Wallis test were used for this analysis, depending on the nature of the studied variables. The collected data are presented in Table S1, Table 7 and Table 8. Table S1 is provided as Supplementary File.
The vast majority of surveyed physicians use basic methods to detect symptoms of developmental disorders—the most common ones include observing the child during the physical examination (94.74%), attempting to communicate and establish contact with the child (93.68%), and assessing the pace of achieving developmental milestones (89.47%). Risks related to family history are slightly less frequently taken into account; diagnostic tools completed by caregivers or healthcare workers are used much less frequently (21.05 and 15.79% of respondents, respectively). Moreover, active use of the above-mentioned methods is more common only in children suspected of having DD features; less frequently in the entire pediatric patient population. Quite a significant part of the surveyed doctors has a wait-and-see attitude in the case of subtle features of DD in a child under two years of age (37.89%); in the case of children over two years of age, the vast majority of doctors refer children with DD symptoms for further evaluation (94.74%). These issues are independent of doctors’ age, gender, place of work and age; the analyzes showed the significance of the percentage of pediatric patients among all patients on the frequency of screening use in the entire population (the highest in the “up to 20%” and “above 50%” groups, not showing a linear nature; X2 = 19.216, p = 0.002), self-estimated IT proficiency on the frequency of referring patients for further evaluation after the age of 2) (the higher it is, the greater the percentage of referring physicians) and the length of work experience in primary care facilities (the longer it is, the more physicians refer patients for further evaluation—both below and over 2 years of age).
As in the case of parents, preferences regarding the type of screening (online vs. stationary) are strongly divided (53.68% of doctors are in favor of online screening). Dependencies were observed only in terms of age and work experience of doctors (younger doctors and those working in primary care for a shorter period more often preferred the online version (H = 27.876, p = 0.046 and H = 24.384, p = 0.041, respectively).
If the stationary version was preferred over the electronic version, we asked doctors who would be responsible for calculating the questionnaire results and analyzing the screening results. The vast majority (n = 36, 81.82%) believe that this should be performed by the child’s doctor; then the doctor with the most experience in DD (n = 6, 13.64%). Interestingly, none of the doctors would hand over this function to nurses or the clinic coordinator (in Poland, these are HCPs responsible for helping patients set appointments with specialists outside the clinic and helping with the care of chronically ill patients).
Physicians were also asked how willing they would be to use questionnaires to perform screening of DDs during individual visits (e.g., peri-vaccination visits, well-child visits, when observing DD symptoms during the visit). The Kruskal–Wallis test was used to perform this analysis. The results are summarized in Table 9.
The respondents’ answers show a clear, statistically significant difference in the willingness to use screening questionnaires during various situations in the physicians’ office (H = 46.069, p < 0.001); doctors are significantly more willing to use screening tools to confirm noticed symptoms (M = 4.362) and to confirm or dispel parents’ doubts (M = 4.362). The willingness to use these methods for general screening is significantly lower (in the case of 18 months—M = 3.512; 24 months—M = 3.828).
While preparing the Polish version of the CSBS-DP ITC questionnaire, we encountered many difficulties reported by healthcare professionals (HCPs) regarding the implementation of additional ASD screening. We collected their and our observations in order to obtain a broader opinion of HCPs potentially responsible for screening. The answers are summarized in Figure 1 and Table S2. Table S2 is provided as Supplementary File.
The surveyed physicians most often point out that there is insufficient time during the patient’s visit to be able to carry out screening test for developmental disorders—this answer was given by almost 92% of doctors. It is also clearly the most frequently occurring most serious obstacle according to doctors; almost half of the respondents point out that excessive time burden is the main barrier to conducting population screening tests. Slightly fewer physicians report difficulties in access to specialists (both the lack of specialists and queues to practicing HCPs) and the lack of clear clinical recommendations regarding DD screening.
Parents and doctors were also asked to rate whether they agreed with the opinions about the positives and negatives of online ASD screening. These opinions were collected based on contacts with parents, specialists and the authors’ own experiences. Chi-square test analysis was performed to obtain results. The respondents’ answers are presented in Table 10.
Both in the groups of doctors and parents, positive features of online screening were more often marked than negative ones. What parents most often appreciate are the convenience of online screening (saving time and the possibility of conducting the test from home—68.18% and 78.23% of parents, respectively) and easier access to the evaluation. Among the negatives, parents most often point out the inability to verify the result and assess the child’s development directly by a specialist (57.89%) and the lack of personal contact with examiners (46.65%). Similar results were obtained among doctors—they also noted the comfort of online screening; however, this effect was significantly lower than in parents (p = 0.025 and 0.002). Doctors also mainly pointed out the lack of direct contact with the person conducting the examination as main flaw of online screening (55.79%). What is noteworthy is that both groups (especially parents) rarely considered a potential lack of trust in people responsible for screening as a disadvantage.

4. Discussion

Conducted study provides evidence for potential benefits of using online ASD screening. Results indicate high parental satisfaction with participation in online screening, with high willingness to participate again for subsequent children. Moreover, most parents and doctors note the need to screen children for ASD. In both groups, there is no clear preference for the screening method (online vs. stationary). However, in order to implement any of the above-mentioned screening methods, the availability of linguistically and culturally adapted tools must be ensured.
In order to increase the effectiveness of early detection of DD, numerous screening questionnaires have been created, which, as research conducted in the United States shows, may be a useful tool to increase the percentage of early detected cases of developmental disorder [17]. In order to enable the use of this method to accelerate the diagnosis of developmental disorders, a version of the CSBS-DP ITC adapted to Polish conditions was prepared by authors of this paper, which was linguistically and culturally adapted to increase the effectiveness of the tool and reduce the likelihood of obtaining incorrect results. When designing the whole project methodology, it was necessary to adapt to the dynamically changing conditions during the COVID-19 pandemic. The pandemic forced the entire study to be conducted online or via telephone consultation. Nevertheless, this form of conducting this study made it possible—apart from assessing the effectiveness of the Polish version of the CSBS-DP ITC—to examine how parents evaluate on-line screening method.
Preparing a Polish version of a fully validated ASD screening questionnaire could, at least partially, fill the gap related to the low frequency of use of diagnostic methods in the field of developmental disorders in the daily work of doctors, as evidenced by our study results. Polish doctors more often use their own clinical assessment of a child’s development, based on assessing the time of reaching appropriate milestones or observing the child’s behavior during visit, which, unfortunately, may result in a delay in diagnosis [17]. The use of tools in the practice of Polish primary care physicians is clearly lower than, for example, in the USA (where ASD screening programs are the most popular—63% of pediatricians use screening questionnaires in their practice, and up to 73% of all children are screened in this direction) which allows for lowering the average age of ASD diagnosis [43,44]. Another example of unintentional omissions may be the quite large percentage of Polish physicians observing the child’s development in the event of subtle symptoms of developmental disorders in children under two years of age—almost half of the respondents would continue close observation or refer the child for further evaluation based on parental pressure, which may also lead to a potential delay in the detection of developmental disorders. In the case of an older child (over 2 years of age), only 5% of respondents would decide to further observe the development.
The most frequently raised issue by respondents, which may potentially hinder the implementation of a screening program for developmental disorders in Poland, is the insufficient amount of time that can be allocated for screening during a visit of a young patient. Paying attention to the occurrence of ASD symptoms in a child or conducting an appropriate screening test requires spending more time on these activities than is usually allocated to a visit to a primary care facility [45]. Insufficient time during the visit to conduct observations for ASD is also the most frequently mentioned obstacle in studies conducted in other countries, e.g., the USA, Canada or Oman [46,47,48,49]. The problem of time constraints is becoming more crucial—data from the UK show increasing workload for doctors and nurses working in primary care [50]. In Poland, this problem is probably even more severe due to the shortage of doctors and the resulting overwork—the number of practicing doctors and nurses in Poland is among the lowest in the EU and amounts to 2.4 doctors and 5.1 nurses per 1000 inhabitants; this problem is particularly severe in small counties around large cities and in rural areas [51]. However, there is a lack of precise data on the professional burden of Polish HCPs—in one of the studies conducted during the COVID-19 pandemic, Polish healthcare workers reported high levels of burnout and stress—related to, among others, increased workload [52]. Rising costs may also be a problem, including costs related to the preparation of materials for screening (although, as the collected data indicate, according to Polish doctors, this should not be a major obstacle) or, above all, with further care for children with suspected or ultimately diagnosed ASD. Healthcare financing in Poland is lower than the EU average (6.5% to 9.9% of GDP in 2019), most of which is spent on inpatient care; funds for outpatient care are half of the average in the European Union [51]. Low expenditure on outpatient healthcare and a small number of practicing HCPs are also related to the issue of difficulties in access to specialists in the immediate area, which is pointed out by as many as 54% of doctors—psychologists, speech therapists, educators, and child psychiatrists. Over the last decade (2014–2023), the number of child psychiatrists in Poland increased from 346 to 532, while in the years 2019–2023 there was an increase in the number of patients from nearly 150,000 to over 266,000, which means that the difficulties in obtaining appropriate specialist help are constantly increasing [53]. This is an important problem because experience from other countries (e.g., Taiwan) indicates that only increasing access to ASD screening without improving access to further evaluation or therapy may cause increasing frustration and confusion in families due to the lack of a coherent procedural and diagnostic system for people at risk of DD. To address the unmet needs of families with children with ASD, resource imbalances between screening and follow-up interventions in public pediatric care settings must be simultaneously addressed [54].
Another problem potentially troubling the implementation of screening is the lack of appropriate education of HCPs and the lack of systemic activities regarding the early diagnosis of ASD—gaps in knowledge regarding ASD and the ability to use screening tools are indicated by 33 and 36% of respondents, respectively. An even greater percentage of doctors report uncertainty regarding further treatment of a patient suspected of having ASD. Insufficient knowledge about ASD among physicians is a common global problem—a study conducted in 2020 showed that only 23% of primary care physicians had sufficient knowledge about ASD, and the percentage of such doctors was higher in countries with higher income [55]. This is probably due to the lack of experience in working with people with disabilities during medical studies, the small number of classes devoted to developmental disorders, as well as the specific image of people with ASD created by the mass media [56]. The problem of a lack of knowledge is intensified by the lack of clear guidelines (either Polish or European) regarding ASD screening and further diagnostic activities. Existing American guidelines do not fully correspond to the Polish primary care setting and their recommendations are difficult to implement into practice.
In Poland, fully validated screening questionnaires for ASD are virtually unavailable, which is indicated by 30% of respondents as a barrier to the implementation of screening. In addition to the mentioned work on the CSBS-DP ITC, so far, there are only preliminary data on the Polish version of Quantitative Checklist for Autism in Toddlers (Q-CHAT). Research on most frequently used in Poland M-CHAT organized as part of the Badabada project is still in progress [57,58]. To datew, direct translations of the above-mentioned questionnaires available on the Internet were usually used without any cultural and linguistic adaptation and without a validation process. Using incorrectly prepared diagnostic tools may reduce the accuracy of the diagnostic process; the diagnostic tool should be fully adapted to the population in which it will be used so that its psychometric properties are at the highest possible level [59]. Nevertheless, the vast majority of physicians would be willing to use diagnostic materials if they were available, especially when detecting clinically significant signs of developmental disorders or to allay or confirm parental concerns. Unfortunately, there is significantly less willingness in physicians to use these tools during peri-vaccination or well-child visits at 18 or 24 months of age, which would be the recommended course of action according to American Academy of Pediatrics guidelines [60]. Experience from preliminary screening programs in Spain and the Netherlands indicates that the use of screening methods for ASD during well-baby check-up visits increases the attendance rate [61]. Less willingness to conduct population screening may lead to delays in diagnosis, especially in the case of more subtle symptoms occurring in a child with undiagnosed DD.
Additionally, blurred responsibility for a child with DD makes it difficult to further guide the child in the diagnostic and therapeutic process. Care for a child with DD in Poland is divided into healthcare (within primary care clinics, specialist mental health clinics, community psychological care centers and early intervention centers) and educational care (within special/integrated kindergartens, psychological and pedagogical counseling centers, early childhood supporting child development and leading centers coordinating rehabilitation and care (pol. Wiodący Ośrodek Koordynujący Rehabilitacyjno-Opiekuńczy, WOKRO)). The multitude of facilities whose scope of competences are sometimes unclear and unregulated (e.g., early intervention centers do not have their own legal normative acts) means that obtaining appropriate, full assistance can be troublesome for child’s guardians who are placed in a stressful situation. The difficult situation is complemented by the fact that some of the mentioned forms of support are insufficient for all those in need—for example, in Poland, there are only forty early intervention centers [62]. The situation is further complicated by the fact that due to the underfunding of the public system, parents often use private healthcare. This significantly complicates the coordination of ASD diagnosis and therapy in Poland. Similar difficulties are also observed in other European countries—a survey conducted in south-eastern European countries indicates that many parents experienced difficulties or delays in therapy due to queues to specialists, high costs or difficulties in obtaining information; difficulties also concerned problems with obtaining assistance in the field of education [63].
The results of our study prove that respondents more often pay attention to the positive rather than negative effects of electronic screening. Both the groups of doctors and parents indicated primarily the convenience of this solution method, which is consistent with previous research results on the use of teleconsultations and online services in healthcare, which unanimously note greater availability and convenience of use compared to stationary services [64]. However, parents most often pointed out as a flaw that screening is carried out solely on the basis of a questionnaire completed by the parent, without direct contact with the examiner who could observe the child (and potentially confirm or deny the diagnosis resulting from screening). This is probably related to the subjective assessment of the doctor’s role as more important during the diagnostic process—not only related to the doctor’s experience, but also to interpersonal and communication qualifications, as well as empathy and understanding. Research data indicate that over 50% of patients do not fully believe in medical suggestions using artificial intelligence (AI), even though AI achieves better diagnostic results in some issues [65]. Probably, even in the case of a simple screening questionnaire (such as the CSBS-DP ITC), the issue of trust in the doctor is an important aspect for parents; it was proven that patients were more willing to implement recommendations given by doctors than those given by computers [66,67]. This effect may be even more important due to the fact that the diagnosis of ASD in a child is associated with a huge caregiving burden, even greater than for parents of children with Down syndrome or type 1 diabetes [68]. Preliminary information collected during this study indicates the need to take this fact into account when designing subsequent ASD screening services.
The collected data show that for parents the ability to initially confirm or deny fears is very important—despite this, the vast majority of parents believe that ASD screening should be mandatory for every child and that they would subject their next child to a similar test—regardless of the form of screening. Interestingly, both doctors and parents show an almost equal division in preferences for online or stationary screening. In the case of implementing the former in a larger population, attention should be paid to the possible effect of digital exclusion, observed more often among people with lower IT proficiency and from rural areas. Nevertheless, conducting diagnostic methods using electronic technologies potentially should speed up the provision of medical assistance and facilitate access to screening [69].
Despite all the positives regarding online screening described above, conducting screening with usage of online technologies is not yet popular—as of 29 November 2023, the phrase “electronic screening” is found in 275 and “online screening” in 258 scientific articles contained in the PubMed database. In the same database, only 2 studies on ASD screening can be found—one conducted in Italy, the other in China—assessing only the effectiveness of ASD online screening [70,71]. Additionally, one large study evaluates the effectiveness of screening using electronic techniques during inpatient visits [72]. We found no study addresses the issue of online screening assessment by parents or doctors. Our work is likely to be the beginning of a future discussion on the role of further online electronic services in the daily work of physicians.
The last issue worth mentioning is the fact that parents whose children were finally diagnosed with DD had previously suspected the occurrence of some developmental disorders in their children. Due to the fact that similar experiences also result from previous studies, it is worth paying attention in everyday practice to the possibilities of dispelling these concerns of caregivers as safely as possible—even in the case of negative tests and screening observations [73].

Limitations

This study has several limitations. Firstly, parents’ assessment of satisfaction with the screening was in some cases carried out a considerable time after the end of participation in this study—this may result in an incomplete and slightly inadequate assessment. Moreover, the selection of the study group does not fully reflect the structure of Polish society. The answers in the section regarding parents’ assessment were provided almost exclusively by mothers—this is consistent with the sex structure obtained in previous studies on the diagnostic accuracy of the CSBS-DP ITC and is probably related to the culturally preferred family model in Poland, where mothers take most of the care of offspring, especially when children they are younger [74]. Percentage of people with higher education and living in large cities took part more often in the ASD screening during the “Spojrzeć w oczy” project; their participation increased even further in this study [75]. Similarly, the largest group of surveyed doctors are those living in large urban centers, with potential underrepresentation of rural areas of Poland. A large part of the surveyed physicians were younger doctors—residents—who are also overrepresented in the study group. Ultimately, both parents and doctors participated in this study completely voluntarily—there is a risk of biasing the group among people with a keen interest in the subject of ASD, which may result in inflated results regarding, for example, awareness of ASD issues or more frequent use of additional diagnostic materials. The methods used in the statistical analysis also pose certain limitations. Due to the lack of normal distribution of the studied features, it was necessary to use non-parametric tests with lower power than parametric tests. Moreover, due to the lack of homogeneity in the diagnostic methods used by doctors or potential restrictions on the implementation of ASD screening in the Polish primary care setting only a descriptive interpretation was possible to perform.

5. Conclusions

The data collected from our study clearly prove that Polish parents and doctors expect the implementation of screening for developmental disorders as part of routine child healthcare. However, this requires resolving numerous possible obstacles—primarily time constraints, human resources and systemic difficulties. Online screening could partially facilitate access to the test and reduce the workload, but it must be introduced with taking into account limitations—especially the possibility of quick verification of the screening result using more accurate methods during stationary visits. Moreover, it will not fully replace the doctor–patient relationship. However, it may be one of the ways to speed up the diagnostic and therapeutic process, which may improve the functioning of people affected by ASD.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/brainsci14040388/s1, Table S1: The usage of screening diagnostic methods for developmental disorders in the practice of Polish family doctors and pediatricians; Table S2: Potential obstacles to the implementation of screening in primary healthcare facilities according to surveyed physicians; File S1: Survey for parents; File S2: Survey for family doctors and pediatricians.

Author Contributions

Conceptualization, M.S. and M.M.B.-F.; methodology, M.S. and M.M.B.-F.; validation, M.S. and M.M.B.-F.; formal analysis, M.S.; investigation, M.S., U.G.-B. and M.M.B.-F.; resources, M.S.; data curation, M.S.; writing—original draft preparation, M.S., U.G.-B. and M.M.B.-F.; writing—review and editing, M.S. and M.M.B.-F.; visualization, M.S.; supervision, M.M.B.-F.; project administration, M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Bioethics Committee of Wroclaw Medical University (KB—641/2020, approved 21 October 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The data presented in this study are openly available in FigShare at https://doi.org/10.6084/m9.figshare.25465744.

Acknowledgments

The researchers would like to thank Róża Hajkuś and Kamila and Tomasz Chadaj for their help in recruiting study participants.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Association Publishing: Washington, DC, USA, 2013. [Google Scholar] [CrossRef]
  2. Zeidan, J.; Fombonne, E.; Scorah, J.; Ibrahim, A.; Durkin, M.S.; Saxena, S.; Yusuf, A.; Shih, A.; Elsabbagh, M. Global Prevalence of Autism: A Systematic Review Update. Autism Res. 2022, 15, 778–790. [Google Scholar] [CrossRef] [PubMed]
  3. Piskorz-Ogórek, K.; Ogórek, S.; Cieślińska, A.; Kostyra, E. Autism in Poland in Comparison to Other Countries. Pol. Ann. Med. 2015, 22, 35–40. [Google Scholar] [CrossRef]
  4. Skonieczna-Żydecka, K.; Gorzkowska, I.; Pierzak-Sominka, J.; Adler, G. The Prevalence of Autism Spectrum Disorders in West Pomeranian and Pomeranian Regions of Poland. J. Appl. Res. Intellect. Disabil. 2017, 30, 283–289. [Google Scholar] [CrossRef]
  5. Bachmann, C.J.; Gerste, B.; Hoffmann, F. Diagnoses of Autism Spectrum Disorders in Germany: Time Trends in Administrative Prevalence and Diagnostic Stability. Autism 2018, 22, 283–290. [Google Scholar] [CrossRef] [PubMed]
  6. Salari, N.; Rasoulpoor, S.; Rasoulpoor, S.; Shohaimi, S.; Jafarpour, S.; Abdoli, N.; Khaledi-Paveh, B.; Mohammadi, M. The Global Prevalence of Autism Spectrum Disorder: A Comprehensive Systematic Review and Meta-Analysis. Ital. J. Pediatr. 2022, 48, 112. [Google Scholar] [CrossRef] [PubMed]
  7. Zwaigenbaum, L.; Bryson, S.; Garon, N. Early Identification of Autism Spectrum Disorders. Behav. Brain Res. 2013, 251, 133–146. [Google Scholar] [CrossRef] [PubMed]
  8. Canu, D.; Van der Paelt, S.; Canal-Bedia, R.; Posada, M.; Vanvuchelen, M.; Roeyers, H. Early Non-Social Behavioural Indicators of Autism Spectrum Disorder (ASD) in Siblings at Elevated Likelihood for ASD: A Systematic Review. Eur. Child Adolesc. Psychiatry 2021, 30, 497–538. [Google Scholar] [CrossRef]
  9. Chawarska, K.; Klin, A.; Paul, R.; Volkmar, F. Autism Spectrum Disorder in the Second Year: Stability and Change in Syndrome Expression. J. Child Psychol. Psychiatry Allied Discip. 2007, 48, 128–138. [Google Scholar] [CrossRef] [PubMed]
  10. Orinstein, A.J.; Helt, M.; Troyb, E.; Tyson, K.E.; Barton, M.L.; Eigsti, I.M.; Naigles, L.; Fein, D.A. Intervention for Optimal Outcome in Children and Adolescents with a History of Autism. J. Dev. Behav. Pediatr. 2014, 35, 247–256. [Google Scholar] [CrossRef]
  11. MacDonald, R.; Parry-Cruwys, D.; Dupere, S.; Ahearn, W. Assessing Progress and Outcome of Early Intensive Behavioral Intervention for Toddlers with Autism. Res. Dev. Disabil. 2014, 35, 3632–3644. [Google Scholar] [CrossRef]
  12. Smith, T.; Klorman, R.; Mruzek, D.W. Predicting Outcome of Community-Based Early Intensive Behavioral Intervention for Children with Autism. J. Abnorm. Child Psychol. 2015, 43, 1271–1282. [Google Scholar] [CrossRef] [PubMed]
  13. Lai, M.C.; Kassee, C.; Besney, R.; Bonato, S.; Hull, L.; Mandy, W.; Szatmari, P.; Ameis, S.H. Prevalence of Co-Occurring Mental Health Diagnoses in the Autism Population: A Systematic Review and Meta-Analysis. Lancet Psychiatry 2019, 6, 819–829. [Google Scholar] [CrossRef]
  14. Mello, C.; Rivard, M.; Terroux, A.; Mercier, C. Quality of Life in Families of Young Children with Autism Spectrum Disorder. Am. J. Intellect. Dev. Disabil. 2019, 124, 535–548. [Google Scholar] [CrossRef] [PubMed]
  15. Papadopoulos, A.; Siafaka, V.; Tsapara, A.; Tafiadis, D.; Kotsis, K.; Skapinakis, P.; Tzoufi, M. Measuring Parental Stress, Illness Perceptions, Coping and Quality of Life in Families of Children Newly Diagnosed with Autism Spectrum Disorder. BJPsych Open 2023, 9, e84. [Google Scholar] [CrossRef]
  16. Hyman, S.L.; Levy, S.E.; Myers, S.M.; Kuo, D.Z.; Apkon, C.S.; Davidson, L.F.; Ellerbeck, K.A.; Foster, J.E.A.; Noritz, G.H.; O’Connor Leppert, M.; et al. Identification, Evaluation, and Management of Children with Autism Spectrum Disorder. Pediatrics 2020, 145, e20193447. [Google Scholar] [CrossRef]
  17. Shaw, K.A.; Maenner, M.J.; Baio, J.; Washington, A.; Christensen, D.L.; Wiggins, L.D.; Pettygrove, S.; Andrews, J.G.; White, T.; Rosenberg, C.R.; et al. Early Identification of Autism Spectrum Disorder among Children Aged 4 Years—Early Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2016. MMWR Surveill. Summ. 2020, 69, 1–11. [Google Scholar] [CrossRef]
  18. Maenner, M.J.; Shaw, K.A.; Baio, J.; Washington, A.; Patrick, M.; DiRienzo, M.; Christensen, D.L.; Wiggins, L.D.; Pettygrove, S.; Andrews, J.G.; et al. Prevalence of Autism Spectrum Disorder among Children Aged 8 Years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016. MMWR Surveill. Summ. 2020, 69, 1–12. [Google Scholar] [CrossRef] [PubMed]
  19. Siu, A.L. Screening for Autism Spectrum Disorder in Young Children US Preventive Services Task Force Recommendation Statement. J. Am. Med. Assoc. 2016, 315, 691–696. [Google Scholar] [CrossRef]
  20. Sheldrick, R.C.; Merchant, S.; Perrin, E.C. Identification of Developmental-Behavioral Problems in Primary Care: A Systematic Review. Pediatrics 2011, 128, 356–363. [Google Scholar] [CrossRef]
  21. Fein, D. Commentary on USPSTF Final Statement on Universal Screening for Autism. J. Dev. Behav. Pediatr. 2016, 37, 573–578. [Google Scholar] [CrossRef]
  22. Coury, D.L. Babies, Bathwater, and Screening for Autism Spectrum Disorder: Comments on the USPSTF Recommendations for Autism Spectrum Disorder Screening. J. Dev. Behav. Pediatr. 2015, 36, 661–663. [Google Scholar] [CrossRef]
  23. Mandell, D.; Mandy, W. Should All Young Children Be Screened for Autism Spectrum Disorder? Autism 2015, 19, 895–896. [Google Scholar] [CrossRef]
  24. Greig, A.; Constantin, E.; Carsley, S.; Cummings, C.; Amit, M.; Grueger, B.; Feldman, M.; Lang, M.; Grabowski, J.; Wong, D.; et al. Preventive Health Care Visits for Children and Adolescents Aged Six to 17 Years: The Greig Health Record—Executive Summary. Paediatr. Child Health 2010, 15, 157. [Google Scholar] [CrossRef] [PubMed]
  25. Rourke, L.; Godwin, M.; Rourke, J.; Pearce, S.; Bean, J. The Rourke Baby Record Infant/Child Maintenance Guide: Do Doctors Use It, Do They Find It Useful, and Does Using It Improve Their Well-Baby Visit Records? BMC Fam. Pract. 2009, 10, 28. [Google Scholar] [CrossRef] [PubMed]
  26. James, S.N.; Smith, C.J. Early Autism Diagnosis in the Primary Care Setting. Semin. Pediatr. Neurol. 2020, 35, 100827. [Google Scholar] [CrossRef] [PubMed]
  27. Oblacińska, A.; Jodkowska, M.; Sawiec, P. ABC Bilansów Zdrowia Dziecka. Podręcznik Dla Lekarzy; Medycyna Praktyczna: Kraków, Poland, 2017. (In Polish) [Google Scholar]
  28. Jaroszyńska-Szymczuk, M. Orientacyjne Badanie Rozwoju Motorycznego i Psychospołecznego Pod Kątem Dojrzałości Szkolnej Dziecka. In Profilaktyczne Badania Lekarskie i Inne Zadania Lekarza w Opiece Zdrowotnej nad Uczniami; Oblacińska, A., Woynarowska, B., Eds.; Instytut Matki i Dziecka: Warszawa, Poland, 2002; pp. 65–66. (In Polish) [Google Scholar]
  29. Lenart, A.; Pasternak, J. Resources, Problems and Challenges of Autism Spectrum Disorder Diagnosis and Support System in Poland. J. Autism Dev. Disord. 2023, 53, 1629–1641. [Google Scholar] [CrossRef]
  30. Chojnicka, I.; Pisula, E. Adaptation and Validation of the ADOS-2, Polish Version. Front. Psychol. 2017, 8, 1916. [Google Scholar] [CrossRef] [PubMed]
  31. Wrocławska-Warchala, E.; Wójcik, R. ASRS Zestaw Kwestionariuszy Do Diagnozy Spektrum Autyzmu; Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego: Warszawa, Poland, 2016. (In Polish) [Google Scholar]
  32. Pisula, E. Profil Psychoedukacyjny, Wydanie 3, Wersja Polska. Podręcznik Diagnosty; EduProf: Warszawa, Poland, 2019; ISBN 9788395381102. (In Polish) [Google Scholar]
  33. Rynkiewicz, A.; Szura, M.; Bernaciak, D.; Kozak, A.; Karwowska, M. Polish Adaptation of the Social Communication Questionnaire (SCQ) and Female Autism Phenotype: An Investigation of Potentially Sex-Biased Items in the Screening Assessment and Their Impact on Scores. Brain Sci. 2021, 11, 682. [Google Scholar] [CrossRef] [PubMed]
  34. Lord, C.; Rutter, M.; Le Couteur, A. Autism Diagnostic Interview-Revised: A Revised Version of a Diagnostic Interview for Caregivers of Individuals with Possible Pervasive Developmental Disorders. J. Autism Dev. Disord. 1994, 24, 659–685. [Google Scholar] [CrossRef]
  35. Wetherby, A.M.; Allen, L.; Cleary, J.; Kublin, K.; Goldstein, H. Validity and Reliability of the Communication and Symbolic Behavior Scales Developmental Profile with Very Young Children. J. Speech Lang. Hear. Res. 2002, 45, 1202–1218. [Google Scholar] [CrossRef]
  36. Sobieski, M.; Kopszak, A.; Wrona, S.; Bujnowska-Fedak, M.M. Screening Accuracy and Age-Based Scoring Procedures of the Polish Version of Communication and Symbolic Behavior Scales-Developmental Profile Infant-Toddler Checklist. medRxiv 2024, preprint. [Google Scholar] [CrossRef]
  37. Sobieski, M.; Wrona, S.; Flakus, M.; Pierchała, K.; Sobieska, A.; Podgórska, K.; Wołowicz, A.; Sekułowicz, M.; Bujnowska-Fedak, M.M. Reliability and Theoretical Validity of the Polish Version of Communication and Symbolic Behavior Scales-Developmental Profile—Infant-Toddler Checklist. SSRN 2023, 4573426. [Google Scholar] [CrossRef]
  38. Kruszyńska-Fischbach, A.; Sysko-Romańczuk, S.; Rafalik, M.; Walczak, R.; Kludacz-Alessandri, M. Organizational E-Readiness for the Digital Transformation of Primary Healthcare Providers during the COVID-19 Pandemic in Poland. J. Clin. Med. 2022, 11, 133. [Google Scholar] [CrossRef] [PubMed]
  39. Siow, M.Y.; Walker, J.T.; Britt, E.; Kozy, J.P.; Zanzucchi, A.; Girard, P.J.; Schwartz, A.K.; Kent, W.T. What Was the Change in Telehealth Usage and Proportion of No-Show Visits for an Orthopaedic Trauma Clinic during the COVID-19 Pandemic? Clin. Orthop. Relat. Res. 2020, 478, 2257–2263. [Google Scholar] [CrossRef] [PubMed]
  40. Lu, X.; Yao, Y.; Jin, Y. Digital Exclusion and Functional Dependence in Older People: Findings from Five Longitudinal Cohort Studies. EClinicalMedicine 2022, 54, 101708. [Google Scholar] [CrossRef] [PubMed]
  41. Greer, B.; Robotham, D.; Simblett, S.; Curtis, H.; Griffiths, H.; Wykes, T. Digital Exclusion among Mental Health Service Users: Qualitative Investigation. J. Med. Internet Res. 2019, 21, e11696. [Google Scholar] [CrossRef] [PubMed]
  42. Schmidt, S.A.J.; Lo, S.; Hollestein, L.M. Research Techniques Made Simple: Sample Size Estimation and Power Calculation. J. Investig. Dermatol. 2018, 138, 1678–1682. [Google Scholar] [CrossRef] [PubMed]
  43. Carbone, P.S.; Campbell, K.; Wilkes, J.; Stoddard, G.J.; Huynh, K.; Young, P.C.; Gabrielsen, T.P. Primary Care Autism Screening and Later Autism Diagnosis. Pediatrics 2020, 146, 20192314. [Google Scholar] [CrossRef] [PubMed]
  44. Lipkin, P.H.; Macias, M.M.; Chen, B.B.; Coury, D.; Gottschlich, E.A.; Hyman, S.L.; Sisk, B.; Wolfe, A.; Levy, S.E. Trends in Pediatricians’ Developmental Screening: 2002–2016. Pediatrics 2020, 145, e20190851. [Google Scholar] [CrossRef]
  45. Buckley, C. Making Your Practice Autism Friendly. InnovAiT Educ. Inspir. Gen. Pract. 2017, 10, 327–331. [Google Scholar] [CrossRef]
  46. Das, J.; Hartman, L.; King, G.; Jones-Stokreef, N.; Moore Hepburn, C.; Penner, M. Perspectives of Canadian Rural Consultant Pediatricians on Diagnosing Autism Spectrum Disorder: A Qualitative Study. J. Dev. Behav. Pediatr. 2022, 43, 149–158. [Google Scholar] [CrossRef] [PubMed]
  47. Morelli, D.L.; Pati, S.; Butler, A.; Blum, N.J.; Gerdes, M.; Pinto-Martin, J.; Guevara, J.P. Challenges to Implementation of Developmental Screening in Urban Primary Care: A Mixed Methods Study. BMC Pediatr. 2014, 14, 16. [Google Scholar] [CrossRef] [PubMed]
  48. Dosreis, S.; Weiner, C.L.; Johnson, L.; Newschaffer, C.J. Autism Spectrum Disorder Screening and Management Practices among General Pediatric Providers. J. Dev. Behav. Pediatr. 2006, 27, S88–S94. [Google Scholar] [CrossRef] [PubMed]
  49. Al Maskari, T.; Melville, C.; Al Farsi, Y.; Wahid, R.; Willis, D. Qualitative Exploration of the Barriers to, and Facilitators of, Screening Children for Autism Spectrum Disorder in Oman. Early Child Dev. Care 2020, 190, 1762–1777. [Google Scholar] [CrossRef]
  50. Hobbs, F.D.R.; Bankhead, C.; Mukhtar, T.; Stevens, S.; Perera-Salazar, R.; Holt, T.; Salisbury, C. Clinical Workload in UK Primary Care: A Retrospective Analysis of 100 Million Consultations in England, 2007–14. Lancet 2016, 387, 2323–2330. [Google Scholar] [CrossRef] [PubMed]
  51. OECD/European Observatory on Health Systems and Policies. Spain: Country Health Profile 2021; OECD: Paris, France, 2021. [Google Scholar]
  52. Izdebski, Z.; Kozakiewicz, A.; Białorudzki, M.; Dec-Pietrowska, J.; Mazur, J. Occupational Burnout in Healthcare Workers, Stress and Other Symptoms of Work Overload during the COVID-19 Pandemic in Poland. Int. J. Environ. Res. Public Health 2023, 20, 2428. [Google Scholar] [CrossRef]
  53. Opłakany Stan Psychiatrii Dziecięcej—Aktualności—Psychiatria Dzieci i Młodzieży—Medycyna Praktyczna Dla Lekarzy. Available online: https://www.mp.pl/psychiatria-dzieci-i-mlodziezy/aktualnosci/320826,oplakany-stan-psychiatrii-dzieciecej (accessed on 29 January 2024). (In Polish).
  54. Yi, H.; Siu, Q.K.Y.; Ngan, O.M.Y.; Chan, D.F.Y. Parents’ Experiences of Screening, Diagnosis, and Intervention for Children with Autism Spectrum Disorder. Am. J. Orthopsychiatry 2020, 90, 297–311. [Google Scholar] [CrossRef] [PubMed]
  55. McCormack, G.; Dillon, A.C.; Healy, O.; Walsh, C.; Lydon, S. Primary Care Physicians’ Knowledge of Autism and Evidence-Based Interventions for Autism: A Systematic Review. Rev. J. Autism Dev. Disord. 2020, 7, 226–241. [Google Scholar] [CrossRef]
  56. Havercamp, S.M.; Ratliff-Schaub, K.; Macho, P.N.; Johnson, C.N.; Bush, K.L.; Souders, H.T. Preparing Tomorrow’s Doctors to Care for Patients with Autism Spectrum Disorder. Intellect. Dev. Disabil. 2016, 54, 202–216. [Google Scholar] [CrossRef]
  57. Niedźwiecka, A.; Pisula, E. Symptoms of Autism Spectrum Disorders Measured by the Qualitative Checklist for Autism in Toddlers in a Large Sample of Polish Toddlers. Int. J. Environ. Res. Public Health 2022, 19, 3072. [Google Scholar] [CrossRef]
  58. Badabada. Pl—M-CHAT-R/F PL. Available online: http://badabada.pl (accessed on 23 March 2024). (In Polish).
  59. DuBay, M.; Watson, L.R.; Baranek, G.T.; Lee, H.; Rojevic, C.; Brinson, W.; Smith, D.; Sideris, J. Rigorous Translation and Cultural Adaptation of an Autism Screening Tool: First Years Inventory as a Case Study. J. Autism Dev. Disord. 2021, 51, 3917–3928. [Google Scholar] [CrossRef] [PubMed]
  60. Zwaigenbaum, L.; Bauman, M.L.; Stone, W.L.; Yirmiya, N.; Estes, A.; Hansen, R.L.; McPartland, J.C.; Natowicz, M.R.; Choueiri, R.; Fein, D.; et al. Early Identification of Autism Spectrum Disorder: Recommendations for Practice and Research. Pediatrics 2015, 136, S10–S40. [Google Scholar] [CrossRef] [PubMed]
  61. García-Primo, P.; Hellendoorn, A.; Charman, T.; Roeyers, H.; Dereu, M.; Roge, B.; Baduel, S.; Muratori, F.; Narzisi, A.; Van Daalen, E.; et al. Screening for Autism Spectrum Disorders: State of the Art in Europe. Eur. Child Adolesc. Psychiatry 2014, 23, 1005–1021. [Google Scholar] [CrossRef] [PubMed]
  62. Wyszukaj Placówki—Umów Wizytę. Available online: https://placowki.mp.pl/home/szukaj.html?is_pharmacy=0&name=ośrodek+wczesnej+interwencji&find=Szukaj&specs[0]=&offset=20 (accessed on 29 January 2024). (In Polish).
  63. Daniels, A.M.; Como, A.; Hergüner, S.; Kostadinova, K.; Stosic, J.; Shih, A. Autism in Southeast Europe: A Survey of Caregivers of Children with Autism Spectrum Disorders. J. Autism Dev. Disord. 2017, 47, 2314–2325. [Google Scholar] [CrossRef] [PubMed]
  64. Ford, J.; Reuber, M. Comparisons of Communication in Medical Face-To-Face and Teleconsultations: A Systematic Review and Narrative Synthesis. Health Commun. 2023, 39, 1012–1026. [Google Scholar] [CrossRef] [PubMed]
  65. Robertson, C.; Woods, A.; Bergstrand, K.; Findley, J.; Balser, C.; Slepian, M.J. Diverse Patients’ Attitudes towards Artificial Intelligence (AI) in Diagnosis. PLoS Digit. Health 2023, 2, e0000237. [Google Scholar] [CrossRef] [PubMed]
  66. Shaffer, V.A.; Probst, C.A.; Merkle, E.C.; Arkes, H.R.; Medow, M.A. Why Do Patients Derogate Physicians Who Use a Computer-Based Diagnostic Support System? Med. Decis. Mak. 2013, 33, 108–118. [Google Scholar] [CrossRef] [PubMed]
  67. Promberger, M.; Baron, J. Do Patients Trust Computers? J. Behav. Decis. Mak. 2006, 19, 455–468. [Google Scholar] [CrossRef]
  68. Picardi, A.; Gigantesco, A.; Tarolla, E.; Stoppioni, V.; Cerbo, R.; Cremonte, M.; Alessandri, G.; Lega, I.; Nardocci, F. Parental Burden and Its Correlates in Families of Children with Autism Spectrum Disorder: A Multicentre Study with Two Comparison Groups. Clin. Pract. Epidemiol. Ment. Health 2018, 14, 143–176. [Google Scholar] [CrossRef]
  69. Hincapié, M.A.; Gallego, J.C.; Gempeler, A.; Piñeros, J.A.; Nasner, D.; Escobar, M.F. Implementation and Usefulness of Telemedicine During the COVID-19 Pandemic: A Scoping Review. J. Prim. Care Community Health 2020, 11, 1–7. [Google Scholar] [CrossRef]
  70. Colombo, P.; Buo, N.; Ceccarelli, S.B.; Molteni, M. Integrating a New Online Platform in Primary Care for Early Detection, Referral, and Intervention in Autism Spectrum Disorder: The First Italian Pivotal Clinical Study. Brain Sci. 2022, 12, 256. [Google Scholar] [CrossRef] [PubMed]
  71. Qiu, T.; Zhang, H.; Zhou, C.; Tang, Q.; Wang, L.; Ke, X. Application of Telemedicine for Preliminary Screening of Autism Spectrum Disorder. Front. Pediatr. 2022, 9, 745597. [Google Scholar] [CrossRef] [PubMed]
  72. Guthrie, W.; Wallis, K.; Bennett, A.; Brooks, E.; Dudley, J.; Gerdes, M.; Pandey, J.; Levy, S.E.; Schultz, R.T.; Miller, J.S. Accuracy of Autism Screening in a Large Pediatric Network. Pediatrics 2019, 144, e20183963. [Google Scholar] [CrossRef] [PubMed]
  73. Ryan, S.; Salisbury, H. ‘You Know What Boys Are like’: Pre-Diagnosis Experiences of Parents of Children with Autism Spectrum Conditions. Br. J. Gen. Pract. 2012, 62, e378–e383. [Google Scholar] [CrossRef] [PubMed]
  74. Zięba-Kołodziej, B. Partnerstwo Rodziców w Opiece Nad Dzieckiem i w Jego Wychowywaniu. In Rodzicielstwo w Kontekście Współczesnych Przemian Społecznych; Brągiel, J., Górnicka, B., Eds.; Wydawnictwo Uniwersytetu Opolskiego: Opole, Poland, 2012; pp. 149–163. ISBN 978-83-7395-505-9. (In Polish) [Google Scholar]
  75. Polish Central Statistical Office. Mały Rocznik Statystyczny Polski/Concise Statistical Yearbook of Poland; Główny Urząd Statystyczny: Warszawa, Poland, 2022. [Google Scholar]
Figure 1. Obstacles to the implementation of screening in primary healthcare facilities according to surveyed physicians.
Figure 1. Obstacles to the implementation of screening in primary healthcare facilities according to surveyed physicians.
Brainsci 14 00388 g001
Table 1. Sociodemographic characteristics of parents taking part in this study.
Table 1. Sociodemographic characteristics of parents taking part in this study.
Characteristic n%
Sex
Female41799.76%
Male10.24%
Using additional contact with researchers
Yes389.09%
No38090.91%
Diagnosed DD in their child during the project
Yes30 (21 ASD, 8 LD, 1 SI)7.18%
No38892.82%
Education level
Lower education00%
Secondary education5813.88%
Higher education 36086.12%
Place of residence
Village9923.68%
Town inhabited by less than 20,000 people337.89%
City inhabited by 20,000–100,000 people5914.11%
City inhabited by more than 100,000 people22754.31%
Note. Secondary education is basic vocational, general or technical secondary education with or without a high school diploma and post-secondary studies which are not higher education). DD—developmental disorders.
Table 2. Opinions on ASD screening (also online) and awareness of the problem among parents depending on place of residence, education and final diagnosis of the child.
Table 2. Opinions on ASD screening (also online) and awareness of the problem among parents depending on place of residence, education and final diagnosis of the child.
Number of Positive ResponsesNumber of Negative Responses% of Positive ResponsesdfΧ2p
Before screening, had you heard about ASD?
Place of residency 13.0130.005
Village95495.96%3
Town inhabited by less than 20,000 people330100%
City inhabited by 20,000–100,000 people590100%
City inhabited by more than 100,000 people2270100%
Education level 13.398<0.001
Secondary education54493.10%1
Higher education3600100%
Received diagnosis of DD
Yes300100%10.3120.576
No384498.97%
Has it occurred to you that there may be possibility that your children may have ASD?
Place of residency 9.5810.022
Village504950.51%3
Town inhabited by less than 20,000 people231069.70%
City inhabited by 20,000–100,000 people253442.37%
City inhabited by more than 100,000 people1369159.91%
Education level 0.1890.663
Secondary education322655.17%1
Higher education20215856.11%
Received diagnosis of DD
Yes26486.67%112.350<0.001
No20818053.61%
Should screening for ASD be mandatory?
Place of residency 6.7490.081
Village990100%3
Town inhabited by less than 20,000 people31293.94%
City inhabited by 20,000–100,000 people590100%
City inhabited by more than 100,000 people221697.36%
Education level 1.0280.311
Secondary education56296.55%1
Higher education354698.33%
Received diagnosis of DD
Yes300100%10.6310.427
No380897.94%
Would you participate in screening for ASD in your other children?
Place of residency 8.4970.037
Village990100%3
Town inhabited by less than 20,000 people31293.94%
City inhabited by 20,000–100,000 people57296.61%
City inhabited by more than 100,000 people225299.12%
Education level 0.9130.339
Secondary education580100%1
Higher education354698.33%
Received diagnosis of DD
Yes300100%10.4710.493
No382698.45%
Would you participate in online screening for ASD in your other children?
Place of residency 11.4290.010
Village96396.97%3
Town inhabited by less than 20,000 people29487.88%
City inhabited by 20,000–100,000 people58198.31%
City inhabited by more than 100,000 people223498.24%
Education level 0.1430.705
Secondary education56296.55%1
Higher education3501097.22%
Received diagnosis of DD
Yes28293.33%11.6700.196
No3781097.42%
Do you prefer screening to be carried out stationary at your clinic?
Place of residency 4.0840.254
Village425742.42%3
Town inhabited by less than 20,000 people191457.58%
City inhabited by 20,000–100,000 people332655.93%
City inhabited by more than 100,000 people10612146.70%
Education level 0.3710.542
Secondary education243441.38%1
Higher education17618448.89%
Received diagnosis of DD
Yes18620247.94%10.4710.493
No141646.67%
Note. ASD—autism spectrum disorders, DD—developmental disorders, df—degrees of freedom, and Χ2—chi-square test statistic result
Table 3. Opinions on ASD screening (also online) and awareness of the problem among parents depending on parents’ age and IT proficiency.
Table 3. Opinions on ASD screening (also online) and awareness of the problem among parents depending on parents’ age and IT proficiency.
VariablesHdfp
Before screening, had you heard about ASD?
Age16.327190.635
IT proficiency14.80150.011
Has it occurred to you that there may be a possibility that your children may have ASD?
Age12.970190.840
IT proficiency8.37450.137
Should screening for DD be mandatory?
Age19.114190.450
IT proficiency3.27750.657
Would you participate in screening for DD in your other children?
Age27.965190.084
IT proficiency7.55050.183
Would you participate in online screening for DD in your other children?
Age16.013190.656
IT proficiency9.91150.078
Do you prefer screening to be carried out stationary at your clinic?
Age9.599190.962
IT proficiency16.21250.006
Note. ASD—autism spectrum disorders, DD—developmental disorders, df—degrees of freedom, and H—Kruskal–Wallis test statistic result.
Table 4. Assessment of online ASD screening conducted in the “Spojrzeć w oczy” project by parents depending on place of residence and education level.
Table 4. Assessment of online ASD screening conducted in the “Spojrzeć w oczy” project by parents depending on place of residence and education level.
VariableMMeSDdfHp
The information available during screening was understandable and easily accessible
Place of residency 3.8210.252
Village4.77350.5163
Town inhabited by less than 20,000 people4.80150.392
City inhabited by 20,000–100,000 people4.92550.254
City inhabited by more than 100,000 people4.75150.532
Education level 1.3170.517
Secondary education4.81150.3811
Higher education4.78150.504
I felt that I could refer any questions regarding my children’s development to the people responsible for screening
Place of residency 10.7940.013
Village4.35050.8963
Town inhabited by less than 20,000 people3.87741.088
City inhabited by 20,000–100,000 people4.28450.760
City inhabited by more than 100,000 people4.00051.003
Education level 1.7100.452
Secondary education3.90051.1651
Higher education4.14450.927
I would receive appropriate help or advice in case of suspicion DD from people involved in online screening
Place of residency 21.323<0.001
Village4.43350.7783
Town inhabited by less than 20,000 people3.91340.918
City inhabited by 20,000–100,000 people4.24050.863
City inhabited by more than 100,000 people3.91940.972
Education level 6.0430.048
Secondary education4.26450.9351
Higher education4.05140.925
Overall, I am satisfied with my participation in electronic ASD screening
Place of residency 3.4500.278
Village4.72250.6393
Town inhabited by less than 20,000 people4.76950.415
City inhabited by 20,000–100,000 people4.70550.544
City inhabited by more than 100,000 people4.65550.607
Education level 2.0670.356
Secondary education4.73450.6141
Higher education4.67950.590
Note. Answers were given on a Likert scale, where 1—I completely disagree with this sentence and 5—I completely agree with this sentence. ASD—autism spectrum disorders, DD—developmental disorders, df—degrees of freedom, H—Kruskal–Wallis test statistic result, M—mean, Me—median, and SD—standard deviation.
Table 5. Assessment of online ASD screening conducted in the “Spojrzeć w oczy” project by parents depending on parents’ age and IT proficiency.
Table 5. Assessment of online ASD screening conducted in the “Spojrzeć w oczy” project by parents depending on parents’ age and IT proficiency.
Variablesrtp
Age & The information available during screening was understandable and easily accessible−0.093−1.8950.059
Age & I felt that I could refer any questions regarding my children’s development to the people responsible for screening−0.104−2.1400.033
Age & I would receive appropriate help or advice in case of suspicion DD from people involved in online screening0.0330.6770.499
Age & Overall, I am satisfied with my participation in electronic ASD screening−0.030−0.6180.537
IT proficiency & The information available during screening was understandable and easily accessible0.0581.1760.240
IT proficiency & I felt that I could refer any questions regarding my children’s development to the people responsible for screening0.0240.4920.623
IT proficiency & I would receive appropriate help or advice in case of suspicion DD from people involved in online screening−0.009−0.1850.853
IT proficiency & Overall, I am satisfied with my participation in electronic ASD screening−0.026−0.5280.598
Note. ASD—autism spectrum disorders, DD—developmental disorders, r—Spearman’s rho statistic result, and t—the value of the t statistic testing the significance of the correlation coefficient.
Table 6. Sociodemographic characteristics of doctors taking part in this study.
Table 6. Sociodemographic characteristics of doctors taking part in this study.
Characteristics (Total N = 95)n%
Sex
Female6265.26%
Male3334.74%
Main place of practicing a profession
Village77.37%
Town inhabited by less than 20,000 people99.47%
City inhabited by 20,000–100,000 people2223.16%
City inhabited by more than 100,000 people5760.00%
Percentage of pediatric patients among all doctor’s patients
up to approx. 10% of total2223.15%
up to approx. 20% of total2728.42%
up to approx. 30% of total1920.00%
up to approx. 40% of total66.32%
up to approx. 50% of total1010.53%
more than 50% of total1111.58%
Table 7. The usage of screening methods, the choice of management in case of suspected DD and preferred screening method (online vs. stationary) depending on the sex, primary place of work of physicians and percentage of pediatric patients among all patients.
Table 7. The usage of screening methods, the choice of management in case of suspected DD and preferred screening method (online vs. stationary) depending on the sex, primary place of work of physicians and percentage of pediatric patients among all patients.
VariableTotal
N = 95
SexΧ2/H*pPrimary Place of WorkΧ2/H*p
Females
N = 62
Males
N = 33
Village
N = 7
Town
N = 9
Small City
N = 22
Big City
N = 57
n%n%n%n%n%n%n%
Usage of screening methods for DD (e.g., ASD) 1.2460.265
in all children3941.05%2845.16%1133.33%228.57%333.33%731.82%2747.37%2.3880.496
in at-risk children or suspected of having DD5557.89%3353.23%2266.67%571.43%666.67%1568.18%2950.88%
lack of use of screening tools11.05%11.61%00.00%00.00%00.00%00.00%11.75%
Management of a child under 2 years of age in the event of subtle symptoms of developmental disorders 0.8970.343
referral for further diagnostics5153.68%3251.61%1957.58%228.57%888.89%1359.09%2849.12%1.1620.762
referral for further diagnostics at the insistence of parents88.42%46.45%412.12%114.29%00.00%29.09%58.77%
further observation of the child’s development3637.89%2641.94%1030.30%457.14%111.11%627.27%2442.11%
Management of a child above 2 years of age in the event of subtle symptoms of developmental disorders 0.5380.463
referral for further diagnostics9094.74%5791.94%33100.00%571.43%9100.00%2195.45%5596.49%12.7060.005
referral for further diagnostics at the insistence of parents11.05%11.61%00.00%114.29%00.00%00.00%00.00%
further observation of the child’s development44.21%46.45%00.00%114.29%00.00%14.55%23.51%
Preferred screening method
stationary4446.32%3048.39%1442.42%0.3040.581342.86%333.33%627.27%3256.14%6.0010.112
on-line5153.68%3251.61%1957.58%457.14%666.67%1672.73%2543.86%
VariablePercentage of Pediatric Patients Among All PatientsΧ2/H*p
<10%
N = 22
<20%
N = 27
<30%
N = 19
<40%
N = 6
<50%
N = 10
>50%
N = 11
n%n%n%n%n%n%
Usage of screening methods for DD (e.g., ASD)
in all children418.18%1866.67%736.84%00.00%330.00%763.64%19.2160.002
in at-risk children or suspected of having DD1881.82%829.63%1263.16%6100.00%770.00%436.36%
lack of use of screening tools00.00%13.70%00.00%00.00%00.00%00.00%
Management of a child under 2 years of age in the event of subtle symptoms of developmental disorders
referral for further diagnostics1568.18%1244.44%1157.89%350.00%660.00%436.36%10.2710.068
referral for further diagnostics at the insistence of parents00.00%13.70%210.53%00.00%220.00%327.27%
further observation of the child’s development731.82%1451.85%631.58%350.00%220.00%436.36%
Management of a child above 2 years of age in the event of subtle symptoms of developmental disorders
referral for further diagnostics2090.91%2696.30%19100.00%6100.00%990.00%1090.91%8.5900.127
referral for further diagnostics at the insistence of parents00.00% 0.00%00.00%00.00%110.00%00.00%
further observation of the child’s development29.09%13.70%00.00%00.00%00.00%19.09%
Preferred screening method
stationary1359.09%1140.74%526.32%466.67%660.00%545.45%6.5240.259
on-line940.91%1659.26%1473.68%233.33%440.00%654.55%
Note. ASD—autism spectrum disorders, DD—developmental disorders, H—Kruskal–Wallis test statistic result, and Χ2—chi-square test statistic result. * Kruskal–Wallis H test used only in preferred screening method analysis.
Table 8. The usage of screening methods, the choice of management in case of suspected DD and preferred screening method (online vs. stationary) depending on the age, estimated number of children with DD under medical care and length of work experience of physicians.
Table 8. The usage of screening methods, the choice of management in case of suspected DD and preferred screening method (online vs. stationary) depending on the age, estimated number of children with DD under medical care and length of work experience of physicians.
VariablesHdfp
Usage of screening methods for DD (in all children/only in children at risk or suspected of DD)
age22.435170.169
self-estimated IT proficiency5.49660.482
estimated number of children with DD under medical care22.133180.226
length of work experience in primary care facilities6.089140.964
Management of a child under 2 years of age in the event of subtle symptoms of developmental disorders
age15.675170.547
self-estimated IT proficiency6.88160.332
estimated number of children with DD under medical care24.169180.150
length of work experience in primary care facilities24.553140.039
Management of a child above 2 years of age in the event of subtle symptoms of developmental disorders
age18.120170.381
self-estimated IT proficiency19.75760.003
estimated number of children with DD under medical care13.250180.777
length of work experience in primary care facilities30.081140.007
Preferred screening method
age27.876170.046
self-estimated IT proficiency5.27760.501
estimated number of children with DD under medical care24.435180.141
length of work experience in primary care facilities24.384140.041
Note. DD—developmental disorders, df—degrees of freedom, and H—Kruskal–Wallis test statistic result.
Table 9. Willingness to use DD screening diagnostic questionnaires during specific visits at primary care facilities.
Table 9. Willingness to use DD screening diagnostic questionnaires during specific visits at primary care facilities.
How Willingly Would You Use Tools for Screening Developmental Disorders in the Following Situations?MMeSDHp
during the vaccination qualifying visit at 18 months of age3.51241.09446.069<0.001
during the well-child visit in 2nd year of life3.82841.022
when noticing symptoms of developmental disorders in child during the visit4.41550.736
when a parent expresses concerns about their child’s development4.36250.735
if the child has a sibling with ASD or another developmental disorder4.20740.787
Note. Answers were given on a Likert scale, where 1—very reluctantly and 5—very willingly. ASD—autism spectrum disorders, H—Kruskal–Wallis test statistic result, M – mean, Me – median, SD – standard deviation,. Three respondents did not provide answers regarding this part.
Table 10. Evaluation of the advantages and positives of online ASD screening by parents and physicians.
Table 10. Evaluation of the advantages and positives of online ASD screening by parents and physicians.
VariableParents
N = 418
Doctors
N = 95
Χ2
(df = 1)
p
n% of Parents% of Total Answersn% of Doctors% of Total Answers
Which of the positives of online ASD screening are the most important to you?
possibility of contact with healthcare professionals qualified in the field of developmental disorders 15336.60%13.08%3132.63%13.19%0.530.466
saving time on screening (possibility to perform screening at home) 28568.18%24.36%6164.21%25.96%0,560.456
no potential stigmatization of the child in the event of developmental disorders (person examining does not personally know the family/child)11828.23%10.09%3031.58%12.77%0.420.515
possibility of performing the test at any convenient time 32778.23%27.95%6467.37%27.23%5.040.025
easier access to the screening (it is not necessary to look for people qualified to perform screening)28768.66%24.53%4951.58%20.85%9.990.002
Total1170n/a100%235n/a100%
What are the greatest difficulties in conducting online screening in your opinion?
lack of direct (physical) contact with the examiner (e.g., doctor, nurse, psychologist)19546.65%29.64%5355.79%31.18%2.590.108
inability to confirm the result of the screening test in clinical observation by a doctor/psychologist 24257.89%36.78%5052.63%29.41%0.870.350
the need to wait for an explanation of the obtained result 5011.96%7.60%1920.00%11.18%3.630.057
inability to quickly clarify doubts regarding the development of the child’s behavior16339.00%24.77%3941.05%22.94%0.140.711
lack of trust in people responsible for online screening 81.91%1.22%99.47%5.29%11.55<0.001
Total658n/a100%170n/a100%
Note. ASD—autism spectrum disorders and Χ2—chi-square test statistic result.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sobieski, M.; Grata-Borkowska, U.; Bujnowska-Fedak, M.M. Implementing an Early Detection Program for Autism Spectrum Disorders in the Polish Primary Healthcare Setting—Possible Obstacles and Experiences from Online ASD Screening. Brain Sci. 2024, 14, 388. https://doi.org/10.3390/brainsci14040388

AMA Style

Sobieski M, Grata-Borkowska U, Bujnowska-Fedak MM. Implementing an Early Detection Program for Autism Spectrum Disorders in the Polish Primary Healthcare Setting—Possible Obstacles and Experiences from Online ASD Screening. Brain Sciences. 2024; 14(4):388. https://doi.org/10.3390/brainsci14040388

Chicago/Turabian Style

Sobieski, Mateusz, Urszula Grata-Borkowska, and Maria Magdalena Bujnowska-Fedak. 2024. "Implementing an Early Detection Program for Autism Spectrum Disorders in the Polish Primary Healthcare Setting—Possible Obstacles and Experiences from Online ASD Screening" Brain Sciences 14, no. 4: 388. https://doi.org/10.3390/brainsci14040388

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop